Icon

BREVITAL SODIUM (nda011559)- (2.5GM/VIAL,5GM/VIAL,200MG/VIAL,500MG/VIAL)

METHOHEXITAL SODIUM ENDO OPERATIONS
2.5GM/VIAL,5GM/VIAL,200MG/VIAL,500MG/VIAL
No No
Expired Expired
None None
None No
BREVITAL can be used in adults as follows: 1. For intravenous induction of anesthesia prior to the use of other general anesthetic agents. 2. For intravenous induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for short surgical procedures; BREVITAL may be given by infusion or intermittent injection. 3. For use along with other parenteral agents, usually narcotic analgesics, to supplement subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for longer surgical procedures. 4. As intravenous anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. 5. As an agent for inducing a hypnotic state. BREVITAL can be used in pediatric patients older than 1 month as follows: 1. For rectal or intramuscular induction of anesthesia prior to the use of other general anesthetic agents. 2. For rectal or intramuscular induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents for short surgical procedures. 3. As rectal or intramuscular anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli.
1 0 1
Total Other Developers None
Drugs with Suitability No
2.5GM/VIAL ** ** - - -
5GM/VIAL ** ** - - -
200MG/VIAL ** ** - - -
500MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ************ ******* ********* ********* ****** ******* *********** **** **.: *-**, ************ ********** ****, **************, *** *****, ****, ************** *****, ********* *****, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.